Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells
Intracerebral delivery of hCNTF has shown considerable neuroprotective potential in animal models of Huntington's disease (HD). The present study describes the relationship between a range of hCNTF doses and the resulting behavioral and neurochemical (striatal ChAT and GAD activity) protection...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2004-10-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/000000004783983404 |
id |
doaj-d98ce942b3854d85b562de9213ec6774 |
---|---|
record_format |
Article |
spelling |
doaj-d98ce942b3854d85b562de9213ec67742020-11-25T03:33:14ZengSAGE PublishingCell Transplantation0963-68971555-38922004-10-011310.3727/000000004783983404Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing CellsDwaine F. Emerich Ph.D.0LCT BioPharma, Inc., 241 Anan Wade Road, Glocester, RI 02857Intracerebral delivery of hCNTF has shown considerable neuroprotective potential in animal models of Huntington's disease (HD). The present study describes the relationship between a range of hCNTF doses and the resulting behavioral and neurochemical (striatal ChAT and GAD activity) protection in a rodent model of HD. Encapsulated BHK delivering a range of hCNTF doses were implanted into the lateral ventricle ipsilateral to an intrastriatal quinolinic acid (QA) injection. Results demonstrated a dose-dependent effect of hCNTF with complete, partial, and no observable neuroprotection occurring with preimplant doses of hCNTF of 30.8, 8.6, and 0.8–2.1 ng hCNTF/24 h, respectively. These data continue to support the use of cellular delivery of hCNTF for HD and will facilitate the optimization of this approach in the clinical situation.https://doi.org/10.3727/000000004783983404 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dwaine F. Emerich Ph.D. |
spellingShingle |
Dwaine F. Emerich Ph.D. Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells Cell Transplantation |
author_facet |
Dwaine F. Emerich Ph.D. |
author_sort |
Dwaine F. Emerich Ph.D. |
title |
Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells |
title_short |
Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells |
title_full |
Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells |
title_fullStr |
Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells |
title_full_unstemmed |
Dose-Dependent Neurochemical and Functional Protection Afforded by Encapsulated CNTF-Producing Cells |
title_sort |
dose-dependent neurochemical and functional protection afforded by encapsulated cntf-producing cells |
publisher |
SAGE Publishing |
series |
Cell Transplantation |
issn |
0963-6897 1555-3892 |
publishDate |
2004-10-01 |
description |
Intracerebral delivery of hCNTF has shown considerable neuroprotective potential in animal models of Huntington's disease (HD). The present study describes the relationship between a range of hCNTF doses and the resulting behavioral and neurochemical (striatal ChAT and GAD activity) protection in a rodent model of HD. Encapsulated BHK delivering a range of hCNTF doses were implanted into the lateral ventricle ipsilateral to an intrastriatal quinolinic acid (QA) injection. Results demonstrated a dose-dependent effect of hCNTF with complete, partial, and no observable neuroprotection occurring with preimplant doses of hCNTF of 30.8, 8.6, and 0.8–2.1 ng hCNTF/24 h, respectively. These data continue to support the use of cellular delivery of hCNTF for HD and will facilitate the optimization of this approach in the clinical situation. |
url |
https://doi.org/10.3727/000000004783983404 |
work_keys_str_mv |
AT dwainefemerichphd dosedependentneurochemicalandfunctionalprotectionaffordedbyencapsulatedcntfproducingcells |
_version_ |
1724563842429616128 |